Spots Global Cancer Trial Database for pediatric all
Every month we try and update this database with for pediatric all cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Study of CD19-directed Allogeneic Memory T-cell Therapy for Relapsed/Refractory CD19+ Leukemia | NCT04881240 | Acute Lymphobla... Acute Lymphobla... Pediatric ALL | CD19-CAR(Mem) T... Cyclophosphamid... Fludarabine Mesna CliniMACS Leukapheresis | - 21 Years | St. Jude Children's Research Hospital | |
| Reduced IV Fluids to Improve Clearance of HDMTX in Children w/Lymphoma or Acute Lymphoblastic Leukemia | NCT03964259 | Lymphoma Acute Lymphobla... Pediatric Cance... Pediatric ALL Pediatric Lymph... | Intravenous flu... | 1 Year - 17 Years | Virginia Commonwealth University | |
| Management of Ovarian Masses in Pediatric Patients: an Italian Survey | NCT05800613 | Ovarian Cysts Pediatric ALL Diagnosis | Survey | - | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | |
| A Study Evaluating the Safety and Activity of Pegylated Recombinant Human Arginase (BCT-100) | NCT03455140 | Cancer Pediatric Solid... Pediatric AML Pediatric ALL | PEG- BCT-100 | 1 Year - 25 Years | University of Birmingham | |
| Healthy Bones, Healthy Life: Habitual Physical Activity on Bone & Metabolic Health in Pediatric Cancer Survivors | NCT04472286 | Acute Lymphobla... Pediatric ALL Pediatric Lymph... Bone Loss Metabolic Syndr... Habitual Physic... Precursor Cell ... Lymphoma Leukemia Lymphoid Leukem... Pediatric Osteoporosis Osteoporosis Ri... | 5 Years - 18 Years | University of Nebraska | ||
| A Phase II Randomized Controlled Trial to Determine the Efficacy of an auGmented reAlity gaMe in pediatrIc caNcer Patients Who Are Opioid Naïve Undergoing Surgery to Reduce Postoperative Opioid Use (GAMING-ON Study) | NCT05466994 | Pediatric ALL Cancer | IPAD Augmented Reali... | 5 Years - 15 Years | M.D. Anderson Cancer Center | |
| Phase II Study of Clofarabine in Pediatric Acute Lymphoblastic Leukemia (ALL) | NCT00042341 | Leukemia, Lymph... | clofarabine (IV... | - 21 Years | Sanofi | |
| Study of CD19-directed Allogeneic Memory T-cell Therapy for Relapsed/Refractory CD19+ Leukemia | NCT04881240 | Acute Lymphobla... Acute Lymphobla... Pediatric ALL | CD19-CAR(Mem) T... Cyclophosphamid... Fludarabine Mesna CliniMACS Leukapheresis | - 21 Years | St. Jude Children's Research Hospital | |
| A Study of CD19 Targeted CAR T Cell Therapy in Pediatric Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukaemia (B ALL) and Aggressive Mature B-cell Non-Hodgkin Lymphoma (B NHL) | NCT06173518 | Relapsed or Ref... Relapsed or Ref... | AUTO1 | 0 Years - 18 Years | Autolus Limited | |
| A Study Evaluating the Safety and Activity of Pegylated Recombinant Human Arginase (BCT-100) | NCT03455140 | Cancer Pediatric Solid... Pediatric AML Pediatric ALL | PEG- BCT-100 | 1 Year - 25 Years | University of Birmingham | |
| Healthy Bones, Healthy Life: Habitual Physical Activity on Bone & Metabolic Health in Pediatric Cancer Survivors | NCT04472286 | Acute Lymphobla... Pediatric ALL Pediatric Lymph... Bone Loss Metabolic Syndr... Habitual Physic... Precursor Cell ... Lymphoma Leukemia Lymphoid Leukem... Pediatric Osteoporosis Osteoporosis Ri... | 5 Years - 18 Years | University of Nebraska |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
